3-Attachment A - eClinical Works- eCW-HL7-Lab-Results-Specifications-v-2.3-November-2015.pdf

PDF 351 KB Posted

Attached to
Medical Laboratory Services
Solicitation number
RFB-RC-2026-011
Issued by
Rockland County, New York

About this file

This is a technical specification document for eClinicalWorks HL7 Lab Results messaging standards, created in November 2015, which establishes the data format requirements for laboratory result transmission to the eClinicalWorks electronic health record system. The document defines the structure and field requirements for HL7 (Health Level 7) messages used to transmit laboratory results, including routine chemistry, hematology, microbiology, toxicology, and pathology findings. The specification outlines nine primary message segments: MSH (Message Header), PID (Patient Identification), PV1 (Patient Visit), ORC (Common Order), OBR (Observation Request), OBX (Observation/Result), and NTE (Notes and Comments), each with detailed field definitions, character length requirements, and mandatory versus optional designations. The document includes message delimiters, encoding conventions, and provides three complete sample messages demonstrating standard lab results, microbiology culture results, and pathology reports as practical implementation examples.

The specification establishes technical requirements for healthcare laboratory data exchange with eClinicalWorks, addressing the integration needs for Rockland County, New York's Medical Laboratory Services contract, which encompasses testing for the Correctional Facility, Department of Health, Department of Mental Health, and Medical Examiner's Office. The document supports all testing categories referenced in the county's laboratory services procurement, including routine chemistry and hematology, microbiology, toxicology, STI/Public Health Panels, forensic and medical examiner testing, correctional health panels, and molecular/PCR testing. By defining standardized message formats with required fields for patient demographics, test orders, and results with abnormal flags and reference ranges, this specification enables reliable electronic transmission of laboratory data across the county's various departments and the eClinicalWorks system infrastructure.

View the file

Other files

On GovTribe

Work with this file

  • Download the original file
  • Contacts named in this file
  • Similar government files
  • Ask GovTribe AI about this file

Text version

© eClinicalWorks, 2015. All rights reserved.

eCLINICALWORKS HL7 LAB RESULTS

SPECIFICATION

November 2015

©Copyright eClinicalWorks, November 2015 - eClinicalWorks HL7 Lab Results Specification 2

CONTENTS

HL7 LAB RESULTS SPECIFICATIONS FOR ECLINICALWORKS ________________________ 3

Transaction Structure _____________________________________________________________ 3 Hierarchy __________________________________________________________________________ 4

Message Delimiters ______________________________________________________________ 4

Conventions ____________________________________________________________________ 5

MSH – Message Header Segment ___________________________________________________ 5 Sample Output ______________________________________________________________________ 6

PID – Patient Identification ________________________________________________________ 6 Sample Output ______________________________________________________________________ 7

PV1 – Patient Visit _______________________________________________________________ 8 Sample Output ______________________________________________________________________ 8

ORC – Common Order Segment ____________________________________________________ 9 Sample Output ______________________________________________________________________ 9

OBR – Observation Request Segment _______________________________________________ 10 Sample Output _____________________________________________________________________ 11

OBX – Observation/Result Segment ________________________________________________ 12 Sample Output _____________________________________________________________________ 13

NTE – Notes and Comments ______________________________________________________ 13 Sample Output _____________________________________________________________________ 13

Sample Lab Message ____________________________________________________________ 14

Sample Microbiology Culture Message ______________________________________________ 14

Sample Pathology Message _______________________________________________________ 16 Example 1: ________________________________________________________________________ 16 Example 2: ________________________________________________________________________ 16

Appendix: Notices ______________________________________________________________ 18 Trademarks _______________________________________________________________________ 18

Transaction Structure

©Copyright eClinicalWorks, November 2015 - eClinicalWorks HL7 Lab Results Specification 3

HL7 LAB RESULTS SPECIFICATIONS FOR

ECLINICALWORKS

The HL7 results specifications described in this section for eClinicalWorks® are:

Transaction Structure OBR – Observation Request Segment

Message Delimiters OBX – Observation/Result Segment

Conventions MSH – Message Header Segment PID – Patient Identification PV1 – Patient Visit ORC – Common Order Segment

NTE – Notes and Comments Sample Lab Message Sample Microbiology Culture Message Sample Pathology Message

Transaction Structure The following table outlines the transaction structure section of the HL7 message:

Name Description Comments

MSH Message Header This segment should always be present in the ORU message

PID Patient Identification There should be a PID segment to give the patient demographic information

PV1 Patient Visit PV1 segment if present will be used for determining the Physician Information

ORC Common Order PV1 segment if present will be used for determining the Physician Information

OBR Observation Request Order level information is retrieved from this segment and is a required segment

OBX Observation Result Result level information is retrieved from this segment

Message Delimiters

©Copyright eClinicalWorks, November 2015 - eClinicalWorks HL7 Lab Results Specification 4

Name Description Comments

NTE Notes and Comments Segment contains the Comments for the order NTE segments can be received at either PID or OBR or OBX level

Hierarchy In the following hierarchy, braces ({}) indicate where multiple items are allowed, and brackets ([]) indicate items that are optional:

MSH Message Header

PID Patient Identification

[PV1] Patient Visit Info

[ORC] Common Order

OBR Observation Request

OBX Observation Result

[NTE] Notes and Comments

Message Delimiters The following table outlines the message delimiters:

Character Function Character

Segment Terminator <CR> LF

Field Separator | (pipe)

Component Separator ^ (caret)

Repetition Separator ~ (tilde)

Conventions

©Copyright eClinicalWorks, November 2015 - eClinicalWorks HL7 Lab Results Specification 5

Conventions The following table outlines the conventions:

Character Function Character

Required field – this should always be sent R

Optional field – this information will be processed if available O

Not Supported N

MSH – Message Header Segment The Message Header (MSH) segment defines the intent, source, destination, and some specifics of the syntax of a message:

Field Name Segment Name Comment Len R/O

Segment Type ID MSH.00 MSH 3 R

Encoding Characters MSH.01 ^~\& 4 R

Sending Application MSH.02 Sending Application 30 O

Sending Facility MSH.03 Sending Facility 30 O

Receiving Application MSH.04 Receiving Application 30 O

Receiving Facility MSH.05 Receiving Facility 30 O

Message Date & Time MSH.06

Format: YYYYMMDDHHMMSS 14 O

Security MSH.07 Not Supported N

Message Type MSH.08 ORU^R01 R

Message Control ID MSH.09 A number that uniquely identifies the message O

PID – Patient Identification

©Copyright eClinicalWorks, November 2015 - eClinicalWorks HL7 Lab Results Specification 6

Field Name Segment Name Comment Len R/O

Processing ID MSH.10 P-Production T-Test 1 O

Version ID MSH.11 2.x 8 O

Sample Output MSH|^~\&|ECW|TEST6600|1100|BN|201505021451||ORU^R01||P|2.x

PID – Patient Identification The Patient Identifier (PID) segment is used by all applications as the primary means of communicating patient identification information. This segment contains permanent patient identifying and demographic information that is not likely to change frequently:

Field Name Segment

Name Comment Len R/O

Segment Type ID PID.00 PID 3 R

Sequence Number PID.01 Serial Number starting from 1 4 R

Patient ID (Internal ID) PID.02 Patient ID 20 O

Patient ID (External ID) PID.03 Patient MRN 20 O

Alternate Patient ID PID.04 eClinicalWorks Patient Account Number 20 O

Patient Name PID.05 Last Name 60^First Name 60^MI 60 180 R

Mother's Maiden Name PID.06 Not Supported N

Date of Birth PID.07 YYYYMMDD 8 R

PID – Patient Identification

©Copyright eClinicalWorks, November 2015 - eClinicalWorks HL7 Lab Results Specification 7

Field Name Segment

Name Comment Len R/O

Sex PID.08

F – Female M – Male U - Unknown 1 O

Patient Alias PID.09 Not Supported N

Race PID.10 Not Supported N

Patient Address PID.11 Addr1 60^Addr2 50^City 25^ State 10^Zip 12 161 O

County Code PID.12 Not Supported N

Phone number - Home PID.13 NNNNNNNNNN 10 O

Phone number - Business PID.14 Not Supported N

Primary Language PID.15 Not Supported N

Marital Status PID.16 Not Supported N

Religion PID.17 Not Supported N

Patient Account Number PID.18 eClinicalWorks Patient Account Number 20 O

SSN # - Patient PID.19 NNNNNNNNN 9 O

Sample Output PID|1|7779|||Test^Test^||19670502|F||C|123 HIGH WAY^^Westboro^MA^01581|| 5085085085|||||32801465|999999999

PV1 – Patient Visit

©Copyright eClinicalWorks, November 2015 - eClinicalWorks HL7 Lab Results Specification 8

PV1 – Patient Visit The PV1 segment is used to communicate information on a visit-specific basis and is not a required segment for the ORU Message:

Field Name Segment

Name Comment Len R/O

Segment Type ID PV1.00 PV1 3 R

Sequence Number PV1.01 Serial number starting from 1 4 R

Patient Class PV1.02 Not supported N

Assigned Patient Location

PV1.03 Account Number O

Admission Type PV1.04 Not supported N

Pre-Admit Number PV1.05 Not supported N

Prior Patient Location

PV1.06 Not supported N

Attending Doctor PV1.07 Provider Code 20^Last Name 60^FirstName 60 ^MI 60

200 R

Referring Provider PV1.08 Provider Code 20^Last Name 60^FirstName 60 ^MI 60

200 O

Visit ID PV1.19 Customer Specific Accessioning 11 O

Sample Output

PV1|1||110011||||C9999^TEST^DOCTOR^L|G8888^REF^PHY|||||||||||38808

ORC – Common Order Segment

©Copyright eClinicalWorks, November 2015 - eClinicalWorks HL7 Lab Results Specification 9

ORC – Common Order Segment The Common Order (ORC) segment is used to receive fields that are common to all results in a given message (all types of services that are requested). The ORC segment is not required in the ORU message:

Field Name Segment

Name Comment Len R/O

Segment Type ID ORC.00 ORC 3 R

Order Control ORC.01 Not Supported 4 N

Place Order Number ORC.02 Customer Specific Accessioning 11 R

Filler Order Number ORC.03 Not supported N

Placer Group Number ORC.04 Not supported N

Order Status ORC.05 Not supported N

Response Flag ORC.06 Not supported N

Quantity/Timing ORC.07 Not supported N

Parent ORC.08 Not supported N

Date/Time of Transaction ORC.09 YYYYMMDDHHMMSS 14 O

Entered By ORC.10 Not supported N

Verified By ORC.11 Not supported N

Ordering Provider ORC.12 Provider Code 20^Last Name 60^FirstName

60 ^MI 60 200 R

ORC|NW|38808|||||||201503021451|||C9999^TEST^TEST^L

OBR – Observation Request Segment

©Copyright eClinicalWorks, November 2015 - eClinicalWorks HL7 Lab Results Specification 10

OBR – Observation Request Segment At least one OBR segment should be present for each Order Code associated with any PID segment. This segment is mandatory in ORU messages:

Field Name Segment

Name Comment Len R/O

Segment Type ID OBR.00 OBR 3 R

Sequence No OBR.01 Serial Number starting from 1 4 R

Placer Order Number OBR.02 Customer Specific Accessioning 20 R

Filler Order Number OBR.03 Vendor Specimen ID 35 R

Observation Battery Identifier OBR.04 Test Code 60^TestName 255 315 R

Priority OBR.05 Not Supported N

Requested Date/Time OBR.06 Not Supported N

Observation /Specimen Collection Date/Time # OBR.07

Observation Date/Time# Format

YYYYMMDDHHMMSS 26 R

Observation End Date/Time # OBR.08 Not Supported N

Collection Volume OBR.09 Not Supported N

Collector Identifier OBR.10 Not Supported N

Specimen Action Code OBR.11 Not Supported N

Danger Code OBR.12 Not Supported N

Relevant Clinical Information OBR.13 Clinical Information 20 O

Specimen Received Date/Time OBR.14 Not Supported N

OBR – Observation Request Segment

©Copyright eClinicalWorks, November 2015 - eClinicalWorks HL7 Lab Results Specification 11

Field Name Segment

Name Comment Len R/O

Specimen Source OBR.15 Specimen Source 30^Specimen Description 255 275 O

Ordering Provider OBR.16 Provider Code 20^Last Name 60^FirstName

60^MI 60 200 R

Ordering Provider’s Phone Number OBR.17 Not Supported N

Alternate Specimen ID OBR.18 Not Supported N

Result Date/Time # OBR.22 Result Date/Time # Format

YYYYMMDDHHMMSS 26 O

Performing Lab OBR.23

LabName^LabAddr1^LabAddr2^ LabAddrCity^LabAddrState^ LabAddrZip^LabPhone^LabDirTitle^LabDirName 235 O

Result Status OBR.25

P – Preliminary F – Final C – Corrected X – Cancel 1 O

Priority OBR.26 Not Supported N

Courtesy Copies To OBR.28

CC List ~ Separated Provider Code 20^Last Name 60^FirstName 60

^MI 60 140 O

Link to Parent Order OBR.29 Parent Test Code 20^TestName 255 275 O

Sample Output OBR|1|38808||010801^Alphafetoprotein|||201505260900|||||||||C9999^Test^Test||13005 |||||LabCompany^12 Oak St^^Seattle^WA^12345^^^||F|||C4321^Jones^Mary|011234

OBX – Observation/Result Segment

©Copyright eClinicalWorks, November 2015 - eClinicalWorks HL7 Lab Results Specification 12

OBX – Observation/Result Segment This segment is required. It contains the values corresponding to the results:

Field Name Segment

Name Comment Len R/O

Segment Type ID OBX.00 OBX 3 R

Sequence Number OBX.01 Serial Number starting from 1 4 R

Type Value OBX.02

CE – Coded entry NM – Numeric ST – String Data TX - Text 2 R

Observation Identifier OBX.03 Result Code 20^Result Name 200 220 R

Observation Sub-ID OBX.04 Not Supported N

Observation Value OBX.05 Observation Value 200 R

Units OBX.06 Units 15 R

References Range OBX.07 Reference Range 40 R

Abnormal Flags OBX.08

Sample Values:

L – Below Normal H – Above Normal LL – Alert Low HH – Alert High 2 R

Probability OBX.09 Not Supported N

Nature of Abnormal Test OBX.10 Not Supported N

Observation Result Status

OBX.11 P – Preliminary F – Final C – Corrected X - Canceled 1 O

NTE – Notes and Comments

©Copyright eClinicalWorks, November 2015 - eClinicalWorks HL7 Lab Results Specification 13

Field Name Segment

Name Comment Len R/O

Date Last Observation Normal Values

OBX.12 Not Supported N

User Defined Access Checks

OBX.13 Not Supported N

Date/Time of the Observation

OBX.14 Not Supported N

Producer’s ID OBX.15 CODE 60 O

Sample Output

OBX|1|NM|001818^GLUCOSE^L||100||65-109||||F|||201405291024|RN

NTE – Notes and Comments The Notes and Comments (NTE) segment contains notes and comments for lab results and is optional:

Field Name Segment Name Comment Len R/O

Segment Type ID NTE.00 NTE 3 R

Sequence Number NTE.01 Serial Number starting from 1 4 R

Source of Comment NTE.02 Source of comment 8 O

Comment NTE.03 Comment 255 R

NTE|1| |NON-FASTING

Sample Lab Message

©Copyright eClinicalWorks, November 2015 - eClinicalWorks HL7 Lab Results Specification 14

Sample Lab Message

MSH|^~\&|ECLI|TEST6600|1100|BN|20150109115934||ORU^R01||T|2.3

PID|1|1111018|||TEST^TEST^T||19810828|M|||50 MEMORIAL

DRIVE^^NEWPORT^RI^02840||4563460987||||||223449087

PV1|1||||||A12345^Willis^Sam^A|A12345^Willis^Sam^A||||||||||||

OBR|1|53510||1126^5'NUCLEOTIDASE|||201501051726|||||||||A12345^Willis^Sam|||||||So uth West CLINICAL LAB – REFERENCE LAB- BURLINGTON,NC||F|||||

OBX|1|NM|1126^5'NUCLEOTIDASE||38|IU/L|0 - 10|H|||F||||

NTE|1||Test was requested by Dr Willis

NTE|2||*** PLEASE NOTE REFERENCE RANGE CHANGE AS OF 10/31/05

OBR|2|53510||962^BASIC METABOLIC

PANEL|||201501061726|||||||||A12345^Willis^Sam|||||||South West CLINICAL LAB –

REFERENCE LAB- BURLINGTON,NC||F|||||

NTE|1||Test was requested by Dr Willis

NTE|1||Test was performed at lab

OBX|1|NM|1001^GLUCOSE||82|MG/DL|70 - 110||||F

OBX|2|NM|1002^BUN||9|MG/DL|10 - 26|L|||F

OBX|3|NM|1003^CREATININE||0.8|MG/DL|0.6 - 1.6||||F

OBX|4|NM|1004^BUN/CREAT RATIO||12.5||||||F

OBX|5|NM|1008^CALCIUM||10.8|MG/DL|8.3 - 10.6|H|||F

OBX|6|NM|1019^SODIUM||137|MEQ/L|135 - 145||||F

OBX|7|NM|1021^POTASSIUM||4.4|MEQ/L|3.5 - 5.0||||F

NTE|1||Reference Range has been updated

OBX|8|NM|1022^CHLORIDE||104|MEQ/L|98 - 108||||F

OBX|9|NM|1023^CARBON DIOXIDE||25|MEQ/L|23 - 33||||F

Sample Microbiology Culture Message

MSH|^~\&|SQ|1000880|HCM||20150313102244||ORU^R01|20062850000002|T|2.2||||

PID|||8020725^^||HCP^OUTPATTWO^||19760523|M|^^|||||||||0408351538|998020725

NTE||ADDRESS and Phone numbers|Reference laboratories~Springfield~MA~01199~(123)

789-2357~FAX (456) 678-0987

PV1||O|HPSP^||||10622^Willis*^^JAN B.

MD|^||||||||||ROP||||||||||||||||||||||||||200608300000|200609290000|

ORC|RE|167437090|||||||20150315102243|||10178^Jones*^^Mary M||||^|

Sample Microbiology Culture Message

©Copyright eClinicalWorks, November 2015 - eClinicalWorks HL7 Lab Results Specification 15

OBR||167437090||54825^URINE

CULTURE|||201503210100|||||||201409210101|URINE^URINE|00178^PIERANGELO*^^DAVID MD

(BOYLSTO||1.0||W1634||||MC^MB|F||^^^^^R|^~^~^|||||||

OBX|1|ST|56229SD^SPECIMEN DESCRIPTION|1|URINE||||||F|||200609210752|L^MAIN LAB

(BMC)|546^POIRIER^ GARY T

OBX|2|ST|56229SR^SPECIAL REQUESTS|1|NONE||||||F|||200609210752|L^MAIN LAB

(BMC)|546^POIRIER^ GARY T

OBX|3|ST|56229CU^CULTURE|1|>100,000 COL/ML PROVIDENCIA

RUSTIGIANII||||||F|||200610131021|M^MICROBIOLOGY LAB|164^MURLEY-KELLS^ KAREN

OBX|4|ST|56229CU^CULTURE|2|<10,000 COL/ML DIPHTHEROID BACILLI ISOLATED.

SUSCEPTIBILITY TESTING NOT||||||P|||200610131021|M^MICROBIOLOGY LAB|164^MURLEY-

KELLS^ KAREN

OBX|5|ST|56229CU^CULTURE|3| ROUTINELY PERFORMED ON THIS

ISOLATE.||||||P|||200610131021|M^MICROBIOLOGY LAB|164^MURLEY-KELLS^ KAREN

OBX|6|ST|56229RS^REPORT STATUS|1|FINAL

10122006||||||F|||200610131021|M^MICROBIOLOGY LAB|164^MURLEY-KELLS^ KAREN

OBX|7|FT|ZZ00OR^ORGANISM|1|ORGANISM >100,000 COL/ML PROVIDENCIA

RUSTIGIANII||||||F|||200610131021|M^MICROBIOLOGY LAB|164^MURLEY-KELLS^ KAREN

OBX|8|FT|ZZ00ME^METHOD|1|METHOD MIN. INH.

CONC.||||||F|||200610131021|M^MICROBIOLOGY LAB|164^MURLEY-KELLS^ KAREN

OBX|9|FT|ZZ00^SUSCEPTIBILITY|1|AMPICILLIN RESISTANT||R|

|||F|||200610131021|M^MICROBIOLOGY LAB|164^MURLEY-KELLS^ KAREN

OBX|10|FT|ZZ00^SUSCEPTIBILITY|1|CEFAZOLIN

RESISTANT||R||||F|||200610131021|M^MICROBIOLOGY LAB|164^MURLEY-KELLS^ KAREN

OBX|11|FT|ZZ00^SUSCEPTIBILITY|1|CEFEPIME

SUSCEPTIBLE||S||||F|||200610131021|M^MICROBIOLOGY LAB|164^MURLEY-KELLS^ KAREN

OBX|12|FT|ZZ00^SUSCEPTIBILITY|1|CEFOTETAN

SUSCEPTIBLE||S||||F|||200610131021|M^MICROBIOLOGY LAB|164^MURLEY-KELLS^ KAREN

OBX|13|FT|ZZ00^SUSCEPTIBILITY|1|CEFTRIAXONE

SUSCEPTIBLE||S||||F|||200610131021|M^MICROBIOLOGY LAB|164^MURLEY-KELLS^ KAREN

OBX|14|FT|ZZ00^SUSCEPTIBILITY|1|CIPROFLOXACIN

RESISTANT||R||||F|||200610131021|M^MICROBIOLOGY LAB|164^MURLEY-KELLS^ KAREN

OBX|15|FT|ZZ00^SUSCEPTIBILITY|1|GENTAMICIN

SUSCEPTIBLE||S||||F|||200610131021|M^MICROBIOLOGY LAB|164^MURLEY-KELLS^ KAREN

OBX|16|FT|ZZ00^SUSCEPTIBILITY|1|IMIPENEM

SUSCEPTIBLE||S||||F|||200610131021|M^MICROBIOLOGY LAB|164^MURLEY-KELLS^ KAREN

OBX|17|FT|ZZ00^SUSCEPTIBILITY|1|LEVOFLOXACIN

INTERMEDIATE||I||||F|||200610131021|M^MICROBIOLOGY LAB|164^MURLEY-KELLS^ KAREN

OBX|18|FT|ZZ00^SUSCEPTIBILITY|1|NITROFURANTOIN

SUSCEPTIBLE||S||||F|||200610131021|M^MICROBIOLOGY LAB|164^MURLEY-KELLS^ KAREN

OBX|19|FT|ZZ00^SUSCEPTIBILITY|1|PIPERACILLIN/TAZOBAC

SUSCEPTIBLE||S||||F|||200610131021|M^MICROBIOLOGY LAB|164^MURLEY-KELLS^ KAREN

OBX|20|FT|ZZ00^SUSCEPTIBILITY|1|TRIMETH/SULFAMETHOX

SUSCEPTIBLE||S||||F|||200610131021|M^MICROBIOLOGY LAB|164^MURLEY-KELLS^ KAREN

Sample Pathology Message

©Copyright eClinicalWorks, November 2015 - eClinicalWorks HL7 Lab Results Specification 16

Sample Pathology Message

Example 1:

MSH|^~\&|COPATHPLUS||HIS||20140314133800||ORU^R01|1006|P|2

PID|1||2|54321|TEST^TEST||19780726|F|||||9133333333

ORC|RE||PRS07^PathPlus||CM||||200707260932|CLW^Wiser^Cindy

OBR|1||PRS07^CoPathPlus|HIS^Histology|||201404140000|||||||201404140931||12345^Wil lis^Sam||||||200804140931||SP|C|||||||12345^Willis^Sam|

OBX|1|TX|PATHOLOGY REPORT^PATHOLOGY REPORT||PATIENT: TEST,

PATIENT\.br\DOB/AGE/SEX: 3/13/1963 (Age: 44) F\.br\PHONE:

9133333333\.br\ACCT #: \.br\PATIENT #: 54321\.br\\.br\GROSS PATHOLOGY:\.br\A.

The specimen is submitted in formalin, labeled "cervical biopsy at 10 o'clock ".

Received is a segment of whitish-tan soft tissue measuring \S\ cm in maximum dimensions. The tissue is submitted in its entirety in cassette A1.\.br\\.br\B.

The specimen is submitted in formalin, labeled "cervical biopsy at 11 o'clock ".

Received is a segment of whitish-tan soft tissue measuring \S\ cm in maximum dimensions. The tissue is submitted in its entirety in cassette B1.\.br\\.br\C.

The specimen is submitted in formalin, Labeled "skin". The tissue is submitted in its entirety in cassette C1\.br\||||||C

Example 2:

MSH|^~\&|COPATHPLUS||HIS||20140304080700||ORU^R01|1069373|P

PID|1||2|^^^05300|test^test||19780726|F|||LANE^^KANSAS CITY^MO^64114^United States||111-111-1111||||||111-11-1111

ORC|RE||PRC08^CoPathPlus||CM||||200802251207|^xxxx^xxxxx||12345^Willis^Sam^N

OBR|1||PRC084117^CoPathPlus|CYT^Cytology|||201404140000|||||||201404140000||12345^ Willis^Sam||||||200804140000||SP|F|

OBX|1|TX|Report^Report||||||||F

NTE|1||GYNECOLOGIC CYTOLOGY REPORT

NTE|2||

NTE|3||

NTE|4|| CLINICAL HISTORY: Annual gyn exam

NTE|5|

NTE|6|

NTE|7|| LMP/MENSTRUAL HISTORY: LMP: 01/25/08

NTE|8|

NTE|9||

NTE|10||SPECIMEN TYPE/SOURCE: Cytyc ThinPrep Pap - vaginal/cervical/endocervical

Sample Pathology Message

©Copyright eClinicalWorks, November 2015 - eClinicalWorks HL7 Lab Results Specification 17

NTE|11||# OF SLIDES: 1

NTE|12||

Appendix: Notices

©Copyright eClinicalWorks, November 2015 - eClinicalWorks HL7 Lab Results Specification 18

Appendix: Notices

Trademarks eClinicalWorks® eClinicalWorks is a trademark of eClinicalWorks, LLC.

All other trademarks or service marks contained herein are the property of their respective owners.

eClinicalWorks HL7 Lab Results Specification
HL7 Lab Results Specifications for eClinicalWorks
Transaction Structure
Hierarchy
Message Delimiters
Conventions
MSH – Message Header Segment
Sample Output
PID – Patient Identification
Sample Output
PV1 – Patient Visit
Sample Output
ORC – Common Order Segment
Sample Output
OBR – Observation Request Segment
Sample Output
OBX – Observation/Result Segment
Sample Output
NTE – Notes and Comments
Sample Output
Sample Lab Message
Sample Microbiology Culture Message
Sample Pathology Message
Example 1:
Example 2:
Appendix: Notices
Trademarks

File details come from the government source that posted it. Updated .